Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?
Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?

Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also underperformed the sector and the S&P 500, as seen in the chart below

Flex Partners MIT to Drive a Sustainable Manufacturing Future With INM
Flex Partners MIT to Drive a Sustainable Manufacturing Future With INM

Flex Ltd. FLEX recently joined forces with the Massachusetts Institute of Technology (“MIT”) on the Initiative for New Manufacturing (INM) — a cutting-edge Institute-wide project that aspires to

Rivian to Get $1B from VWAGY Soon: Time to Buy RIVN Stock Now?Photo, wide shot, wide-angle lens, soft focus,  Car manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-iZxNvwmEDAT2zuvMswp8MrIk.png?st=2023-05-08T05%3A56%3A42Z&se=2023-05-08T07%3A56%3A42Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T03%3A27%3A06Z&ske=2023-05-09T03%3A27%3A06Z&sks=b&skv=2021-08-06&sig=hpaom2wRNOR4VGolGAMc0MX1MdH9zOmjK0MSBHrfkTo%3D
Rivian to Get $1B from VWAGY Soon: Time to Buy RIVN Stock Now?

California-based electric vehicle (EV) startup Rivian Automotive RIVN generated positive gross profit for the second straight quarter in the first quarter of 2025. With that, it hit the gross profit

OppFi Skyrockets 348% in a Year: Is This the Right Time to Invest?
OppFi Skyrockets 348% in a Year: Is This the Right Time to Invest?

OppFi Inc. OPFI shares have skyrocketed 348.1% in a year, outperforming the 29.2% rise of its industry and the 13.4% rally in the Zacks S&P 500 Composite.

OPFI performed significantly better than

Globant Unveils AI Pods to Revolutionize IT Services Delivery ModelPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Globant Unveils AI Pods to Revolutionize IT Services Delivery Model

Globant S.A. GLOB has introduced a groundbreaking approach to IT services with the launch of AI Pods—a first-of-its-kind subscription model for AI-powered services. AI Pods enable access to

Tullow Oil and Partners Sign MoU to Extend Key Oil & Gas LicensesPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Tullow Oil and Partners Sign MoU to Extend Key Oil & Gas Licenses

Tullow Oil plc TUWOY, an independent oil & gas exploration and production company, along with its partners and the Government of Ghana, have signed a Memorandum of Understanding (MoU) to prolong

ETFs Poised to Win in the MSFT vs. NVDA Market Cap Battle
ETFs Poised to Win in the MSFT vs. NVDA Market Cap Battle

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.

Get it free >>

Want the

Here's Why Investors Should Give Ryder System Stock a Miss Now
Here's Why Investors Should Give Ryder System Stock a Miss Now

Ryder System R is grappling with challenges arising from increased operating expenses and weak liquidity, which are adversely impacting the company’s performance, making it an unattractive choice

CrowdStrike Stock Rises 52% in 3 Months: Time to Hold or Book Profits?
CrowdStrike Stock Rises 52% in 3 Months: Time to Hold or Book Profits?

CrowdStrike Holdings CRWD shares have soared 51.7% over the past three months, outperforming the Zacks Security industry’s 23.5% growth. The stock has also exceeded the returns of other industry

Should You Buy, Hold or Sell Chewy Stock Before Q1 Earnings?
Should You Buy, Hold or Sell Chewy Stock Before Q1 Earnings?

As Chewy Inc. CHWY prepares to unveil its first-quarter fiscal 2025 earnings results on June 11 before market open, investors face an important decision: Should they buy the stock now or hold their

Best Momentum Stocks to Buy for June 9th
Best Momentum Stocks to Buy for June 9th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 9th:

Dycom Industries, Inc. DY: This company that provides specialty contracting

Does QuinStreet (QNST) Have the Potential to Rally 76.84% as Wall Street Analysts Expect?
Does QuinStreet (QNST) Have the Potential to Rally 76.84% as Wall Street Analysts Expect?

Shares of QuinStreet (QNST) have gained 8.1% over the past four weeks to close the last trading session at $16.06, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Believe ZipRecruiter (ZIP) Could Rally 28%: Here's is How to Trade
Wall Street Analysts Believe ZipRecruiter (ZIP) Could Rally 28%: Here's is How to Trade

Shares of ZipRecruiter, Inc. (ZIP) have gained 43.4% over the past four weeks to close the last trading session at $6.25, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet
Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet

Vigil Neuroscience, Inc. (VIGL) closed the last trading session at $7.88, gaining 225.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts See a 25.35% Upside in HubSpot (HUBS): Can the Stock Really Move This High?
Wall Street Analysts See a 25.35% Upside in HubSpot (HUBS): Can the Stock Really Move This High?

HubSpot (HUBS) closed the last trading session at $609.40, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Think The RealReal (REAL) Could Surge 76.88%: Read This Before Placing a Bet
Wall Street Analysts Think The RealReal (REAL) Could Surge 76.88%: Read This Before Placing a Bet

The RealReal (REAL) closed the last trading session at $5.71, gaining 13.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's  What You Should Know
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know

Shares of Sagimet Biosciences Inc. (SGMT) have gained 70.6% over the past four weeks to close the last trading session at $5.56, but there could still be a solid upside left in the stock if

Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a Bet
Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a Bet

Shares of Alvotech (ALVO) have gained 10.1% over the past four weeks to close the last trading session at $10.66, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Think Monte Rosa Therapeutics (GLUE) Could Surge 222.16%: Read This Before Placing a Bet
Wall Street Analysts Think Monte Rosa Therapeutics (GLUE) Could Surge 222.16%: Read This Before Placing a Bet

Shares of Monte Rosa Therapeutics (GLUE) have gained 22.5% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if

Wall Street Analysts Believe Concentra (CON) Could Rally 27.1%: Here's is How to Trade
Wall Street Analysts Believe Concentra (CON) Could Rally 27.1%: Here's is How to Trade

Shares of Concentra Group (CON) have gained 2.9% over the past four weeks to close the last trading session at $22.03, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?

Shares of Apogee Therapeutics Inc. (APGE) have gained 9.9% over the past four weeks to close the last trading session at $40.98, but there could still be a solid upside left in the stock if

Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to TradePhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to Trade

Shares of Phathom Pharmaceuticals, Inc. (PHAT) have gained 184.1% over the past four weeks to close the last trading session at $8.92, but there could still be a solid upside left in the stock if

Wall Street Analysts See a 46.32% Upside in BILL Holdings (BILL): Can the Stock Really Move This High?
Wall Street Analysts See a 46.32% Upside in BILL Holdings (BILL): Can the Stock Really Move This High?

Shares of BILL Holdings (BILL) have gained 2% over the past four weeks to close the last trading session at $45.62, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Believe Birkenstock (BIRK) Could Rally 25.79%: Here's is How to Trade
Wall Street Analysts Believe Birkenstock (BIRK) Could Rally 25.79%: Here's is How to Trade

Shares of Birkenstock (BIRK) have gained 4.1% over the past four weeks to close the last trading session at $54.76, but there could still be a solid upside left in the stock if short-term price

Contango ORE, Inc. (CTGO) Just Flashed Golden Cross Signal: Do You Buy?
Contango ORE, Inc. (CTGO) Just Flashed Golden Cross Signal: Do You Buy?

Contango ORE, Inc. (CTGO) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CTGO's 50-day simple moving average broke out above its